The whole plant of Solanum lyratum THUNB (Solanaceae) is a renowned traditional Chinese medicine. Extracts of this plant and its constituents were reported to exhibit a wide spectrum of biological activities including antitumor, antibacterium, and anti-inflammation.
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2 (CDCl 3 ) 2 (DMSO-d 6 ) , as well as two methyls, four methylenes, two methines, and one quaternary carbon. Based on the above evidence, 1 was deduced to be a sesquiterpenoid with an eudesmane-type skeleton. [6] [7] [8] In the heteronuclear multiple bond connectivity (HMBC) spectrum of 1 ( Fig. 1) , the long-range correlations from H-15a to C-4, from H-15b to C-4, from H-3 to C-15, and from H-5 to C-15 revealed the presence of a double bond across C-4/C-15, while correlations from H-12 to C-7 and from H-13 to C-7 demonstrated that a propane-1,2-diol moiety was attached to C-7. Based on the above data and comprehensive 2D NMR experiments ( 1 H-1 H COSY, HMQC, HMBC), the structure of 1 was established as shown in Fig. 1 . The relative stereochemistry of the chiral centers in 1 was resolved by 2D ROESY data. In the ROESY spectrum ( Fig. 1) , cross peaks were observed from H 3 -14 to H-2, from H-1 to H-5, and from H-5 to H-7. Thus H 3 -14 and H-2 were on the same molecular plane (a-configuration) while H-1, H-5, and H-7 were on the opposite side of the molecular plane (b-configuration).
Compound 2 was isolated as a pale yellow lamellar crystal. The HR-FAB mass spectrum showed a quasi-molecular ion peak [MϩH] ϩ at m/z 249.1491, corresponding to the molecular formula C 15 H 20 O 3 . The IR spectrum showed the presence of a hydroxyl group (3412 cm .6, C-13; 27.0, C-14) indicated the presence of a g,g-dimethyl-g-lactone ring. Furthermore, the signals (d H 6.52, 2H, s, H-9 and H-11; d C 127.7, C-7; 137.5, C-8 and C-12; 115.5, C-9 and C-11; 153.7, C-10; 20.4, C-15 and C-16) were assigned to a symmetric 1,2,4,6-tetrasubstituted benzene ring. Additionally, observation of the cross peaks in the HMBC spectrum from H-6 to C-3, C-7, and C-12, suggested that the aromatic ring moiety was connected to the g,g-dimethyl-g-lactone uint through C-6. Further analyses of 1 H-1 H COSY, HMQC and HMBC spectra (Fig. 2) established the NMR assignments for 2. The relative stereochemistry of the asymmetric center in compound 2 was firmly established from the ROESY spectrum (Fig. 2) The four isolated compounds (1-4) were evaluated for their cytotoxic activities against HONE-1, KB, and HT29 cancer cell lines using the methylene blue dye assay and anticancer drugs etoposide and cisplatin 9, 10) as positive controls. These sesquiterpenoids exhibited significant cytotoxicity as shown in Table 2 .
Experimental
General Experimental Procedures Melting points were determined on an XT-4 micro-melting point apparatus and are uncorrected. Optical rotations were measured on a Perkin-Elmer 241 polarimeter. UV spectra were obtained on a Shimadzu UV-160 spectrophotometer. IR spectra were run on a Perkin-Elmer 683 infrared spectrometer with KBr disks. FAB-MS and HR-FAB-MS were recorded on an Autospec-Ultima ETOF MS spectrometer. NMR spectra were obtained with a Varian Unity BRUKER 400 at 400 MHz C-NMR data, see Table 1 . Antitumoral Cytotoxic Bioassays Human nasopharyngeal carcinoma HONE-1, oral epidermoid carcinoma KB, and colorectal carcinoma HT29 cells were maintained in RPMI-1640 medium supplied with 5% fetal bovine serum. Cells in logarithmic phase were cultured at a density of 50000 cells/ml per well in a 24-well plate. The cells were exposed to various concentrations of the test drugs for 72 h. The methylene blue dye assay was used to evaluate the effects of the tested drugs on cell growth, as described previously.
11) The IC 50 value resulting from 50% inhibition of cell growth was calculated graphically as a comparison with the control. Vol. 57, No. 4 a) IC 50 is defined as the concentration that resulted in a 50% decrease in cell number and the results are meansϮstandard deviation of three independent replicates. The IC 50 greater than 10 mM was considered to be no cytotoxicity. b) Positive control substance.
